National Guideline Clearinghouse | Pembrolizumab for treating advanced melanoma after disease progression with ipilimumab.

National Guideline Clearinghouse | Pembrolizumab for treating advanced melanoma after disease progression with ipilimumab.



National Guideline Clearinghouse Web site maintenance is scheduled for Thursday, February 25, 2016 from 8pm to 12am EST. During this time, the site will be unavailable. We apologize for any inconvenience.

National Institute for Health and Care Excellence (NICE)

• Pembrolizumab for treating advanced melanoma after disease progression with ipilimumab.